Protalix BioTherapeutics, Inc. (NYSE:PLX) Q3 2020 Results Conference Call October 29, 2020 8:30 AM ET Company Participants Chuck Padala - LifeSci Advisors, Investor Relations Dror Bashan - President & Chief Executive Officer Eyal Rubin - Chief Financial Officer Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Operator Greetings and welcome to the Protalix Biopharmaceuticals Third Quarter 2020 Financial Results and Business Update. At this time all participants are in a listen-only mode. ...